Workflow
Initial Business Combination
icon
搜索文档
Bayview Acquisition Corp(BAYAU) - Prospectus
2023-11-18 06:22
As filed with the U.S. Securities and Exchange Commission on November 17, 2023. Registration No. 333-__________ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Bayview Acquisition Corp (I.R.S. Employer Identification Number) Bayview Acquisition Corp 420 Lexington Ave Suite 2446 New York, NY 10170 Tel: (347) 627-0058 (Address, Including Zip Code, and Telephone Number, Including Area Code, of Registrant's Principal Execut ...
Bayview Acquisition(BAYA) - Prospectus
2023-11-18 06:22
As filed with the U.S. Securities and Exchange Commission on November 17, 2023. Registration No. 333-__________ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Bayview Acquisition Corp (Exact name of registrant as specified in its charter) Cayman Islands 6770 N/A (State or Other Jurisdiction of Incorporation or Organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification Number) ...
Aimei Health Technology(AFJK) - Prospectus(update)
2023-10-28 03:25
发行情况 - 公司拟公开发行6000000个单位证券,每个单位10美元,募集资金60000000美元[7][9] - 单位发行价格10美元,承销折扣和佣金0.4美元,公司所得扣除费用前为9.6美元;总发行金额6000万美元,承销折扣和佣金240万美元,公司所得扣除费用前为5760万美元[31] - 本次发行向公众出售的每单位10.1美元存入美国信托账户,资金在特定情况发生时才会释放给公司[33] - 公司授予承销商代表一项45天选择权,可额外购买最多90万个单位以覆盖超额配售[35] - 赞助商同意在私募中以每股10美元价格购买30.5万单位(若超额配售权全部行使则为33.2万单位),总购买价为305万美元(若超额配售权全部行使则为332万美元)[95] 业务合并 - 公司需在发行结束后12个月内完成首次业务合并,若延长则最多24个月,否则将停止运营、赎回公众股份并清算[10][36][80][143][145] - 纳斯达克规则要求首次业务合并的目标业务公平市场价值至少为信托账户余额(扣除递延承销佣金和应付利息税)的80%[81][155][171] - 公司预计首次业务合并后将拥有目标业务100%股权或资产,也可能低于100%但需至少拥有50%有表决权证券[82] 财务数据 - 2023年5月8日,营运资金短缺69,063美元,总资产65,445美元,总负债69,063美元,股东权益(赤字)为3,618美元[139] - 2023年9月30日,营运资金短缺203,567美元,总资产234,949美元,总负债213,567美元,股东权益为21,382美元[139] - 本次发行和私募单位销售净收益约为6130万美元(承销商全额行使超额配售权为7039万美元),用于完成初始业务合并[180] 未来展望 - 公司拟收购生物制药、医疗技术/设备行业或诊断及其他服务领域的小市值企业[72] - 公司关注未来五年有显著增长潜力的医疗保健细分领域公司[74] 风险因素 - 中国政府监管行动和声明可能对公司与中国目标公司的业务合并及运营产生重大不利影响[16] - 若发行人最近一个会计年度经审计合并财务报表中50%或以上的营业收入、利润总额、总资产或净资产来自中国境内公司,且主要业务活动在中国内地进行等,需按《试行办法》进行备案[19][60][88] - 公司可能无法在规定时间内完成首次业务合并,否则将清算,公众股东赎回时每股仅能获得10.10美元或更少,认股权将失效[133][183][185][186] - 公司面临来自私募股权集团、风险投资基金等的激烈竞争,财务资源有限,寻求股东批准可能延迟交易[163] - 特殊目的收购公司数量增加,有吸引力的目标减少,竞争加剧,或增加业务合并成本[189] 其他信息 - 公司注册地为开曼群岛,主要行政办公室位于美国纽约[3] - 公司是空白支票公司,目前没有具体业务合并目标在考虑中[8] - 公司作为“新兴成长公司”,将遵守简化的上市公司报告要求,有资格享受某些报告要求豁免[28][97][98] - 公司将在最多五年内保持新兴成长公司身份,但若三年内非可转换债务或收入超过10.7亿美元,或任何财年第二财季最后一天非关联方持有的股份市值超过7亿美元,将从下一财年起不再是新兴成长公司[99]
Spark I Acquisition Corporation(SPKLU) - Prospectus(update)
2023-09-28 09:43
TABLE OF CONTENTS As filed with the U.S. Securities and Exchange Commission on September 27, 2023 Registration No. 333-273176 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 3 TO FORM S-1 REGISTRATION STATEMENT Under The Securities Act of 193 Spark I Acquisition Corporation (Exact name of Registrant as specified in its charter) Cayman Islands (State or other jurisdiction of incorporation or organization) 6770 (Primary Standard Industrial Classification Code Number) 87-1 ...
Inflection Point Acquisition Corp. II(IPXXU) - Prospectus(update)
2023-05-20 01:17
As filed with the U.S. Securities and Exchange Commission on May 19, 2023 Registration No. 333-271128 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 2 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ____________________________ Inflection Point Acquisition Corp. II (Exact name of registrant as specified in its charter) ____________________________ Cayman Islands 6770 N/A Copies to: (State or other jurisdiction of incorporation or organization) (Prim ...
Ares Acquisition II(AACT) - Prospectus(update)
2023-04-15 05:27
Table of Contents As filed with the United States Securities and Exchange Commission on April 14, 2023 under the Securities Act of 1933, as amended. No. 333-270951 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 2 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Ares Acquisition Corporation II (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Cayman Islands 6770 98-1592112 (Primary St ...
Ares Acquisition II(AACT) - Prospectus(update)
2023-04-08 05:08
Table of Contents As filed with the United States Securities and Exchange Commission on April 7, 2023 under the Securities Act of 1933, as amended. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Ares Acquisition Corporation II (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Cayman Islands 6770 98-1592112 (Primary Standard Industria ...
Ares Acquisition II(AACT) - Prospectus
2023-03-30 05:15
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Table of Contents As filed with the United States Securities and Exchange Commission on March 29, 2023 under the Securities Act of 1933, as amended. FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Ares Acquisition Corporation II (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) Cayman Islands 6770 98-1592112 (Primary Standard Industrial Classification C ...
Trailblazer Merger I(TBMC) - Prospectus(update)
2023-03-11 08:39
Amendment No. 3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Trailblazer Merger Corporation I TABLE OF CONTENTS As filed with the Securities and Exchange Commission on March 10, 2023 Registration No. 333-265914 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1/A (Exact name of registrant as specified in its charter) 87-3710376 (I.R.S. Employer Identification Number) (Address, Including Zip Code, and Telephone Number, Including Area Code, of Registrant's Principal Ex ...
Trailblazer Merger I(TBMC) - Prospectus(update)
2023-01-31 07:01
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Registration No. 333-265914 Washington, D.C. 20549 FORM S-1/A Amendment No. 2 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 TABLE OF CONTENTS As filed with the Securities and Exchange Commission on January 30, 2023 Arie Rabinowitz Chief Executive Officer 510 Madison Avenue Suite 1401 New York, NY 10022 Telephone: 212-586-8224 (Name, Address, Including Zip Code, and Telephone Number, Including Area Code, of Agent for Service) Copies to: | Mitchell S. ...